Century-old Vaccine Protects Type 1 Diabetics from Infectious Diseases
BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall.
Press Release5 Minute ReadJan | 10 | 2022
We are aware of COVID-19 information circulating online evidently reflecting an individual’s personal notes from listening to a talk by Edward Ryan, MD, director of Global Infectious Diseases at MGH. These notes lack context, details, and nuance. For instance, the role that vaccines play in mitigating severe disease or death was not included, and individuals with comorbid conditions should continue to take extra precautions to minimize contracting COVID irrelevant of age.
- Massachusetts General Hospital
BCG-treated individuals had a significantly lower rate of COVID-19 infection compared with the placebo group and a significantly lower rate of infectious diseases overall.
Treatment improved blood oxygen levels and lowered the risk of long-term sensory and motor neurologic symptoms.
Results indicate a link between reduced mobility during the pandemic and greater risk for depressive symptoms.
For lung and heart transplant recipients, vaccine doses beyond the third dose are likely important for maintaining immunity.
Many workers at group homes in Massachusetts serving adults with mental illness or disability perceived very serious effects of the first year of the pandemic on their own health and access to care.
Maternal SARS‐CoV‐2 positivity during pregnancy was associated with nearly two-fold higher odds of a neurodevelopmental diagnosis at 12 months of age among male children.